2023 Q4 Form 20-F Financial Statement

#000110465924051213 Filed on April 24, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $2.373B $10.01B
YoY Change 13.08% 925.49%
Cost Of Revenue $433.5M $1.536B
YoY Change 170.61% 1103.14%
Gross Profit $1.940B $8.472B
YoY Change 0.06% 898.74%
Gross Profit Margin 81.73% 84.65%
Selling, General & Admin $552.9M $2.024B
YoY Change -32.4% 764.23%
% of Gross Profit 28.5% 23.89%
Research & Development $363.1M $1.441B
YoY Change 8.57% 819.84%
% of Gross Profit 18.72% 17.01%
Depreciation & Amortization $60.85M
YoY Change 767.66%
% of Gross Profit 0.72%
Operating Expenses $916.0M $3.465B
YoY Change 11.99% 786.52%
Operating Profit $1.024B $5.007B
YoY Change -8.64% 49.09%
Interest Expense $910.8M
YoY Change 211.37%
% of Operating Profit 18.19%
Other Income/Expense, Net -$16.75M $33.44M
YoY Change -475.54% -224.06%
Pretax Income $1.007B $5.041B
YoY Change -10.5% 1070.92%
Income Tax $125.8M $748.5M
% Of Pretax Income 12.49% 14.85%
Net Earnings $878.2M $4.281B
YoY Change -8.4% 1041.18%
Net Earnings / Revenue 37.0% 42.78%
Basic Earnings Per Share $3.88
Diluted Earnings Per Share $0.79 $3.82
COMMON SHARES
Basic Shares Outstanding 1.105B
Diluted Shares Outstanding 1.120B

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $52.56B $52.56B
YoY Change -5.72% -5.72%
Cash & Equivalents $4.938B $4.938B
Short-Term Investments $3.253B $3.253B
Other Short-Term Assets $191.4M $191.4M
YoY Change 87.18% 38.86%
Inventory
Prepaid Expenses
Receivables $9.996B $9.996B
Other Receivables $32.68B $32.68B
Total Short-Term Assets $95.43B $95.43B
YoY Change 699.96% 3.29%
LONG-TERM ASSETS
Property, Plant & Equipment $224.1M $224.1M
YoY Change 53.66% -34.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $238.6M $238.6M
YoY Change 6.48% -73.91%
Other Assets $1.227B $1.227B
YoY Change 27.1% 71.07%
Total Long-Term Assets $1.708B $1.708B
YoY Change 826.47% -19.16%
TOTAL ASSETS
Total Short-Term Assets $95.43B $95.43B
Total Long-Term Assets $1.708B $1.708B
Total Assets $97.14B $97.14B
YoY Change 701.89% 2.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $64.43B $64.43B
YoY Change -7.15% -7.15%
Accrued Expenses $2.098B $2.098B
YoY Change 105.26% 105.26%
Deferred Revenue
YoY Change
Short-Term Debt $5.652B $5.652B
YoY Change 127.84% 127.84%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $72.43B $72.43B
YoY Change 668.51% -1.49%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $135.5M $135.5M
YoY Change 894.99% -102.79%
Total Long-Term Liabilities $135.5M $135.5M
YoY Change 816.59% -102.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $72.43B $72.43B
Total Long-Term Liabilities $135.5M $135.5M
Total Liabilities $72.57B $72.57B
YoY Change 668.77% -1.46%
SHAREHOLDERS EQUITY
Retained Earnings $1.454B
YoY Change 60.28%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $665.6M
YoY Change 20.08%
Treasury Stock Shares
Shareholders Equity $24.57B $24.57B
YoY Change
Total Liabilities & Shareholders Equity $97.14B $97.14B
YoY Change 701.89% 2.79%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $878.2M $4.281B
YoY Change -8.4% 1041.18%
Depreciation, Depletion And Amortization $60.85M
YoY Change 767.66%
Cash From Operating Activities -$6.337B
YoY Change -1522.8%
INVESTING ACTIVITIES
Capital Expenditures $77.76M
YoY Change -14.09%
Acquisitions
YoY Change
Other Investing Activities -$2.367B
YoY Change -1383.57%
Cash From Investing Activities -$2.444B
YoY Change -20419.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.308B
YoY Change -356.87%
NET CHANGE
Cash From Operating Activities -6.337B
Cash From Investing Activities -2.444B
Cash From Financing Activities 2.308B
Net Change In Cash -6.474B
YoY Change 1312.39%
FREE CASH FLOW
Cash From Operating Activities -$6.337B
Capital Expenditures $77.76M
Free Cash Flow -$6.415B
YoY Change -1907.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001754581
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Registrant Name
EntityRegistrantName
Futu Holdings Ltd
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-38820
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
34/F, United Centre
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
95 Queensway
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
Admiralty
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Hong Kong S.A.R
CY2023 dei Entity Address Country
EntityAddressCountry
CN
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Firm
AuditorFirmId
1424
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers Zhong Tian LLP
CY2023 dei Auditor Location
AuditorLocation
Shenzhen, the People’s Republic of China
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5028898000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4937538000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
632134000
CY2022Q4 us-gaap Cash Segregated Under Other Regulations
CashSegregatedUnderOtherRegulations
50685472000
CY2023Q4 us-gaap Cash Segregated Under Other Regulations
CashSegregatedUnderOtherRegulations
44369310000
CY2023Q4 us-gaap Cash Segregated Under Other Regulations
CashSegregatedUnderOtherRegulations
5680435000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1215000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1232000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
158000
CY2022Q4 futu Term Deposits
TermDeposits
5860000
CY2023Q4 futu Term Deposits
TermDeposits
5540000
CY2023Q4 futu Term Deposits
TermDeposits
709000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
675064000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
3114613000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
398752000
CY2022Q4 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
32000000
CY2023Q4 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
133039000
CY2023Q4 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
17032000
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
27840000
CY2023Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
45949000
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
26676358000
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
32528421000
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
4164491000
CY2022Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
513358000
CY2023Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
293505000
CY2023Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
37576000
CY2022Q4 us-gaap Commissions And Floor Brokerage Receivables
CommissionsAndFloorBrokerageReceivables
5914963000
CY2023Q4 us-gaap Commissions And Floor Brokerage Receivables
CommissionsAndFloorBrokerageReceivables
5189155000
CY2023Q4 us-gaap Commissions And Floor Brokerage Receivables
CommissionsAndFloorBrokerageReceivables
664348000
CY2022Q4 us-gaap Receivables From Clearing Organizations
ReceivablesFromClearingOrganizations
3066953000
CY2023Q4 us-gaap Receivables From Clearing Organizations
ReceivablesFromClearingOrganizations
4244793000
CY2023Q4 us-gaap Receivables From Clearing Organizations
ReceivablesFromClearingOrganizations
543445000
CY2022Q4 futu Receivables From Fund Management Companies And Fund Distributors
ReceivablesFromFundManagementCompaniesAndFundDistributors
79086000
CY2023Q4 futu Receivables From Fund Management Companies And Fund Distributors
ReceivablesFromFundManagementCompaniesAndFundDistributors
151691000
CY2023Q4 futu Receivables From Fund Management Companies And Fund Distributors
ReceivablesFromFundManagementCompaniesAndFundDistributors
19420000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
254310000
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
268504000
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
34376000
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
28507000
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
54691000
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
7002000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
102258000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
135479000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
17345000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
93064302000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
95427511000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
12217223000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
196864000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
224092000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28690000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
239694000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
238556000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
30541000
CY2022Q4 futu Loans And Advances Noncurrent
LoansAndAdvancesNoncurrent
36765000
CY2023Q4 futu Loans And Advances Noncurrent
LoansAndAdvancesNoncurrent
18934000
CY2023Q4 futu Loans And Advances Noncurrent
LoansAndAdvancesNoncurrent
2424000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
965205000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1226754000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
157055000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1438528000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1708336000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
218710000
CY2022Q4 us-gaap Assets
Assets
94502830000
CY2023Q4 us-gaap Assets
Assets
97135847000
CY2023Q4 us-gaap Assets
Assets
12435933000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
52725000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
69018000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8836000
CY2022Q4 srt Payables To Customers
PayablesToCustomers
57209066000
CY2023Q4 srt Payables To Customers
PayablesToCustomers
48762263000
CY2023Q4 srt Payables To Customers
PayablesToCustomers
6242848000
CY2022Q4 us-gaap Due To Correspondent Brokers
DueToCorrespondentBrokers
11815274000
CY2023Q4 us-gaap Due To Correspondent Brokers
DueToCorrespondentBrokers
15648286000
CY2023Q4 us-gaap Due To Correspondent Brokers
DueToCorrespondentBrokers
2003391000
CY2022Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
51867000
CY2023Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
24096000
CY2023Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
3085000
CY2022Q4 futu Payables To Fund Management Companies And Fund Distributors
PayablesToFundManagementCompaniesAndFundDistributors
90801000
CY2023Q4 futu Payables To Fund Management Companies And Fund Distributors
PayablesToFundManagementCompaniesAndFundDistributors
175575000
CY2023Q4 futu Payables To Fund Management Companies And Fund Distributors
PayablesToFundManagementCompaniesAndFundDistributors
22478000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
9864000
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
44109000
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
5647000
CY2022Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
2480532000
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
5651565000
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
723549000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
109416000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
114682000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14682000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1706159000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1939004000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
248243000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
73525704000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
72428598000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9272759000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
101727000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
123335000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15789000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13620000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12183000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1560000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
115347000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
135518000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
17349000
CY2022Q4 us-gaap Liabilities
Liabilities
73641051000
CY2023Q4 us-gaap Liabilities
Liabilities
72564116000
CY2023Q4 us-gaap Liabilities
Liabilities
9290108000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18154442000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18456438000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2362908000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
121363408
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
144498392
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4324565000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5199257000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
665641000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47846000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-49433000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6329000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7079416000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11360890000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1454492000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20861544000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
24568736000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3145442000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
235000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
2995000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
383000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20861779000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24571731000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3145825000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
94502830000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97135847000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12435933000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3913027000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4007642000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3944779000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
505035000
CY2021 us-gaap Interest Income Operating
InterestIncomeOperating
2518198000
CY2022 us-gaap Interest Income Operating
InterestIncomeOperating
3214327000
CY2023 us-gaap Interest Income Operating
InterestIncomeOperating
5536422000
CY2023 us-gaap Interest Income Operating
InterestIncomeOperating
708807000
CY2021 us-gaap Other Income
OtherIncome
684095000
CY2022 us-gaap Other Income
OtherIncome
392058000
CY2023 us-gaap Other Income
OtherIncome
527217000
CY2023 us-gaap Other Income
OtherIncome
67498000
CY2021 us-gaap Revenues
Revenues
7115320000
CY2022 us-gaap Revenues
Revenues
7614027000
CY2023 us-gaap Revenues
Revenues
10008418000
CY2023 us-gaap Revenues
Revenues
1281340000
CY2021 futu Brokerage Commission And Handling Charge Expenses
BrokerageCommissionAndHandlingChargeExpenses
572159000
CY2022 futu Brokerage Commission And Handling Charge Expenses
BrokerageCommissionAndHandlingChargeExpenses
329789000
CY2023 futu Brokerage Commission And Handling Charge Expenses
BrokerageCommissionAndHandlingChargeExpenses
249567000
CY2023 futu Brokerage Commission And Handling Charge Expenses
BrokerageCommissionAndHandlingChargeExpenses
31951000
CY2021 futu Interest Expenses
InterestExpenses
376902000
CY2022 futu Interest Expenses
InterestExpenses
292503000
CY2023 futu Interest Expenses
InterestExpenses
910759000
CY2023 futu Interest Expenses
InterestExpenses
116601000
CY2021 futu Processing And Servicing Costs
ProcessingAndServicingCosts
257003000
CY2022 futu Processing And Servicing Costs
ProcessingAndServicingCosts
373840000
CY2023 futu Processing And Servicing Costs
ProcessingAndServicingCosts
375904000
CY2023 futu Processing And Servicing Costs
ProcessingAndServicingCosts
48126000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
1206064000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
996132000
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
1536230000
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
196678000
CY2021 us-gaap Gross Profit
GrossProfit
5909256000
CY2022 us-gaap Gross Profit
GrossProfit
6617895000
CY2023 us-gaap Gross Profit
GrossProfit
8472188000
CY2023 us-gaap Gross Profit
GrossProfit
1084662000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
805325000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1222077000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1440893000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
184472000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1392070000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
895772000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
710348000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
90943000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
529048000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
931144000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1313464000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
168158000
CY2021 us-gaap Operating Expenses
OperatingExpenses
2726443000
CY2022 us-gaap Operating Expenses
OperatingExpenses
3048993000
CY2023 us-gaap Operating Expenses
OperatingExpenses
3464705000
CY2023 us-gaap Operating Expenses
OperatingExpenses
443573000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
3182813000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
3568902000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
5007483000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
641089000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2478000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-210295000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33442000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4281000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3185291000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3358607000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5040925000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
645370000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
375081000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
413962000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
748479000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
95825000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-17752000
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-13497000
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1728000
CY2021 us-gaap Profit Loss
ProfitLoss
2810210000
CY2022 us-gaap Profit Loss
ProfitLoss
2926893000
CY2023 us-gaap Profit Loss
ProfitLoss
4278949000
CY2023 us-gaap Profit Loss
ProfitLoss
547817000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2810210000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2926944000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
4281474000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
548140000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-51000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2525000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-323000
CY2021 us-gaap Profit Loss
ProfitLoss
2810210000
CY2022 us-gaap Profit Loss
ProfitLoss
2926893000
CY2023 us-gaap Profit Loss
ProfitLoss
4278949000
CY2023 us-gaap Profit Loss
ProfitLoss
547817000
CY2021 us-gaap Profit Loss
ProfitLoss
2810210000
CY2022 us-gaap Profit Loss
ProfitLoss
2926893000
CY2023 us-gaap Profit Loss
ProfitLoss
4278949000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14162000
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3145810000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-123822000
CY2022 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
268000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20861779000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20861779000
CY2023 us-gaap Profit Loss
ProfitLoss
4278949000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
290831000
CY2023 us-gaap Profit Loss
ProfitLoss
547817000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
71020000
CY2022 futu Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Attributable To Parent
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxAttributableToParent
-123840000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1587000
CY2023 futu Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Attributable To Parent
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxAttributableToParent
-203000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2881230000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2803053000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4277362000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
547614000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2881230000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2803086000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4279887000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
547937000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-33000
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2525000
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-323000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2881230000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2803053000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4277362000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
547614000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.34
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.57
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.88
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.30
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.54
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.82
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1200912670
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1139377763
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1104899411
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1104899411
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1219672508
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1151021697
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1119653571
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1119653571
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
8307690000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2810210000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
98913000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19957000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10856524000
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1178755000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
71020000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20985559000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20985559000
CY2022 us-gaap Profit Loss
ProfitLoss
2926893000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
204529000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11166000
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
874692000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1587000
CY2023 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
5285000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24571731000
CY2021 us-gaap Profit Loss
ProfitLoss
2810210000
CY2022 us-gaap Profit Loss
ProfitLoss
2926893000
CY2023 us-gaap Profit Loss
ProfitLoss
4278949000
CY2023 us-gaap Profit Loss
ProfitLoss
547817000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
36436000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54714000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
60849000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7790000
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
3200000
CY2022 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
15619000
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
18080000
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
2315000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-17752000
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-13497000
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1728000
CY2021 futu Impairment From Other Non Current Assets
ImpairmentFromOtherNonCurrentAssets
0
CY2022 futu Impairment From Other Non Current Assets
ImpairmentFromOtherNonCurrentAssets
77217000
CY2023 futu Impairment From Other Non Current Assets
ImpairmentFromOtherNonCurrentAssets
0
CY2023 futu Impairment From Other Non Current Assets
ImpairmentFromOtherNonCurrentAssets
0
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
138234000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-133124000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
66032000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
8454000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
98913000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
204529000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
290831000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37234000
CY2022 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
23059000
CY2023 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
68323000
CY2023 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
8747000
CY2021 us-gaap Interest Income Debt Securities Available For Sale Operating
InterestIncomeDebtSecuritiesAvailableForSaleOperating
26000
CY2022 us-gaap Interest Income Debt Securities Available For Sale Operating
InterestIncomeDebtSecuritiesAvailableForSaleOperating
1728000
CY2023 us-gaap Interest Income Debt Securities Available For Sale Operating
InterestIncomeDebtSecuritiesAvailableForSaleOperating
58950000
CY2023 us-gaap Interest Income Debt Securities Available For Sale Operating
InterestIncomeDebtSecuritiesAvailableForSaleOperating
7547000
CY2021 futu Deferred Income Tax Expense Benefit Including Other Adjustments
DeferredIncomeTaxExpenseBenefitIncludingOtherAdjustments
-21431000
CY2022 futu Deferred Income Tax Expense Benefit Including Other Adjustments
DeferredIncomeTaxExpenseBenefitIncludingOtherAdjustments
-52112000
CY2023 futu Deferred Income Tax Expense Benefit Including Other Adjustments
DeferredIncomeTaxExpenseBenefitIncludingOtherAdjustments
-14769000
CY2023 futu Deferred Income Tax Expense Benefit Including Other Adjustments
DeferredIncomeTaxExpenseBenefitIncludingOtherAdjustments
-1891000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
83695000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
94933000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
110357000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
14129000
CY2021 futu Securities Purchased Under Agreements To Resell Increase Decrease
SecuritiesPurchasedUnderAgreementsToResellIncreaseDecrease
-106203000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-843342000
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-50730000
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6495000
CY2022 futu Securities Purchased Under Agreements To Resell Increase Decrease
SecuritiesPurchasedUnderAgreementsToResellIncreaseDecrease
74203000
CY2023 futu Securities Purchased Under Agreements To Resell Increase Decrease
SecuritiesPurchasedUnderAgreementsToResellIncreaseDecrease
-101039000
CY2023 futu Securities Purchased Under Agreements To Resell Increase Decrease
SecuritiesPurchasedUnderAgreementsToResellIncreaseDecrease
-12936000
CY2021 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
10765123000
CY2022 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-2858601000
CY2023 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
5852341000
CY2023 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
749253000
CY2021 futu Increase Decrease In Accounts Receivables From Clients And Brokers
IncreaseDecreaseInAccountsReceivablesFromClientsAndBrokers
1847898000
CY2022 futu Increase Decrease In Accounts Receivables From Clients And Brokers
IncreaseDecreaseInAccountsReceivablesFromClientsAndBrokers
-1936445000
CY2023 futu Increase Decrease In Accounts Receivables From Clients And Brokers
IncreaseDecreaseInAccountsReceivablesFromClientsAndBrokers
-945661000
CY2023 futu Increase Decrease In Accounts Receivables From Clients And Brokers
IncreaseDecreaseInAccountsReceivablesFromClientsAndBrokers
-121069000
CY2021 futu Increase Decrease In Receivables From Clearing Organizations
IncreaseDecreaseInReceivablesFromClearingOrganizations
717193000
CY2022 futu Increase Decrease In Receivables From Clearing Organizations
IncreaseDecreaseInReceivablesFromClearingOrganizations
1101912000
CY2023 futu Increase Decrease In Receivables From Clearing Organizations
IncreaseDecreaseInReceivablesFromClearingOrganizations
1177840000
CY2023 futu Increase Decrease In Receivables From Clearing Organizations
IncreaseDecreaseInReceivablesFromClearingOrganizations
150794000
CY2021 futu Increase Decrease In Accounts Receivables From Fund Management Companies And Fund Distributors
IncreaseDecreaseInAccountsReceivablesFromFundManagementCompaniesAndFundDistributors
-225282000
CY2022 futu Increase Decrease In Accounts Receivables From Fund Management Companies And Fund Distributors
IncreaseDecreaseInAccountsReceivablesFromFundManagementCompaniesAndFundDistributors
6746000
CY2023 futu Increase Decrease In Accounts Receivables From Fund Management Companies And Fund Distributors
IncreaseDecreaseInAccountsReceivablesFromFundManagementCompaniesAndFundDistributors
72605000
CY2023 futu Increase Decrease In Accounts Receivables From Fund Management Companies And Fund Distributors
IncreaseDecreaseInAccountsReceivablesFromFundManagementCompaniesAndFundDistributors
9295000
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
30953000
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
199714000
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-9737000
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-1247000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6653000
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
8904000
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
9929000
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1271000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
105145000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
445903000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
287513000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
36809000
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-37983000
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
3690000
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
17593000
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
2252000
CY2021 futu Increase Decrease In Payables To Customers And Brokers
IncreaseDecreaseInPayablesToCustomersAndBrokers
16130249000
CY2022 futu Increase Decrease In Payables To Customers And Brokers
IncreaseDecreaseInPayablesToCustomersAndBrokers
2297647000
CY2023 futu Increase Decrease In Payables To Customers And Brokers
IncreaseDecreaseInPayablesToCustomersAndBrokers
-4613791000
CY2023 futu Increase Decrease In Payables To Customers And Brokers
IncreaseDecreaseInPayablesToCustomersAndBrokers
-590686000
CY2021 futu Increase Decrease In Payables To Clearing Organizations
IncreaseDecreaseInPayablesToClearingOrganizations
69516000
CY2022 futu Increase Decrease In Payables To Clearing Organizations
IncreaseDecreaseInPayablesToClearingOrganizations
-341915000
CY2023 futu Increase Decrease In Payables To Clearing Organizations
IncreaseDecreaseInPayablesToClearingOrganizations
-27771000
CY2023 futu Increase Decrease In Payables To Clearing Organizations
IncreaseDecreaseInPayablesToClearingOrganizations
-3555000
CY2021 futu Increase Decrease In Payables To Fund Management Companies And Fund Distributors
IncreaseDecreaseInPayablesToFundManagementCompaniesAndFundDistributors
-70752000
CY2022 futu Increase Decrease In Payables To Fund Management Companies And Fund Distributors
IncreaseDecreaseInPayablesToFundManagementCompaniesAndFundDistributors
34111000
CY2023 futu Increase Decrease In Payables To Fund Management Companies And Fund Distributors
IncreaseDecreaseInPayablesToFundManagementCompaniesAndFundDistributors
84774000
CY2023 futu Increase Decrease In Payables To Fund Management Companies And Fund Distributors
IncreaseDecreaseInPayablesToFundManagementCompaniesAndFundDistributors
10853000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
213981000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
337237000
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
307192000
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
39329000
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
9866000
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-5495000
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
34245000
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
4384000
CY2021 futu Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-79544000
CY2022 futu Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-93093000
CY2023 futu Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-107528000
CY2023 futu Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-13766000
CY2021 us-gaap Increase Decrease In Payables Under Repurchase Agreements
IncreaseDecreaseInPayablesUnderRepurchaseAgreements
-985176000
CY2022 us-gaap Increase Decrease In Payables Under Repurchase Agreements
IncreaseDecreaseInPayablesUnderRepurchaseAgreements
-4467861000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1242937000
CY2023 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
76410167000
CY2023 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
9782505000
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
16862000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10554218000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7009521000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2307957000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3575927000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6407505000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6011971000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3474931000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6337396000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-811352000
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
70456000
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
90520000
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
77763000
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
9956000
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1169715000
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
4061490000
CY2023 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
4755173000
CY2023 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
608787000
CY2022 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
4590834000
CY2023 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
2417221000
CY2023 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
309468000
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
23394000
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
235434000
CY2023 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
11767000
CY2023 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1506000
CY2023 futu Payments To Acquire Term Deposits
PaymentsToAcquireTermDeposits
29282000
CY2023 futu Payments To Acquire Term Deposits
PaymentsToAcquireTermDeposits
3749000
CY2021 futu Maturity Of Term Deposits
MaturityOfTermDeposits
300000000
CY2023 futu Maturity Of Term Deposits
MaturityOfTermDeposits
29882000
CY2023 futu Maturity Of Term Deposits
MaturityOfTermDeposits
3826000
CY2022 futu Payments For Acquisition Net Of Cash Acquired
PaymentsForAcquisitionNetOfCashAcquired
109531000
CY2023 futu Payments For Acquisition Net Of Cash Acquired
PaymentsForAcquisitionNetOfCashAcquired
17536000
CY2023 futu Payments For Acquisition Net Of Cash Acquired
PaymentsForAcquisitionNetOfCashAcquired
2245000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-963565000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
93859000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2444418000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-312949000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10856524000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23492000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16332000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11616000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1487000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1178755000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3145810000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
874692000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
111984000
CY2021 futu Proceeds Repayments From Ipo Loan
ProceedsRepaymentsFromIpoLoan
-300199000
CY2021 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
53483435000
CY2022 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
70806177000
CY2023 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
79581200000
CY2023 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
10188480000
CY2021 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
52313417000
CY2022 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
74686220000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
295478000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
167130000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-135196000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66352000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8495000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15769754000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-820328000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43521758000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59291512000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55715585000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7133055000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59291512000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55715585000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49308080000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6312727000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4555096000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5028898000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4937538000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
632134000
CY2021Q4 us-gaap Cash Segregated Under Other Regulations
CashSegregatedUnderOtherRegulations
54734351000
CY2022Q4 us-gaap Cash Segregated Under Other Regulations
CashSegregatedUnderOtherRegulations
50685472000
CY2023Q4 us-gaap Cash Segregated Under Other Regulations
CashSegregatedUnderOtherRegulations
44369310000
CY2023Q4 us-gaap Cash Segregated Under Other Regulations
CashSegregatedUnderOtherRegulations
5680435000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2065000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1215000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1232000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
158000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59291512000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55715585000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49308080000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6312727000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
367036000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
297998000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
876514000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
112217000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
102890000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
694973000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
698821000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
89467000
CY2021 futu Cash Paid For Amounts Included In Operating Lease Liabilities
CashPaidForAmountsIncludedInOperatingLeaseLiabilities
-89427000
CY2022 futu Cash Paid For Amounts Included In Operating Lease Liabilities
CashPaidForAmountsIncludedInOperatingLeaseLiabilities
-106497000
CY2023 futu Cash Paid For Amounts Included In Operating Lease Liabilities
CashPaidForAmountsIncludedInOperatingLeaseLiabilities
-128160000
CY2023 futu Cash Paid For Amounts Included In Operating Lease Liabilities
CashPaidForAmountsIncludedInOperatingLeaseLiabilities
-16408000
CY2023 futu Purchase Price For Exclusive Option Agreement
PurchasePriceForExclusiveOptionAgreement
1.00
CY2023Q4 futu Material Contract Of Value Of Assets Under Exclusive Option Agreement
MaterialContractOfValueOfAssetsUnderExclusiveOptionAgreement
500000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 11pt 18pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 11pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, related disclosures of contingent assets and liabilities at the balance sheet date, and the reported revenues, costs and expenses during the reported period in the consolidated financial statements and accompanying notes. These accounting estimates reflected in the Group’s consolidated financial statements mainly include, but are not limited to,</span> <span style="font-family:'Arial','Helvetica','sans-serif';">current expected credit losses on financial instruments, the valuation and recognition of share-based compensation arrangements, depreciable lives of property and equipment, useful life of intangible assets, assessment for impairment of long-term investments and other non-current assets, present value for expected future leasing payment, contingency reserve, provision of income tax and valuation allowance for deferred tax asset,</span> <span style="font-family:'Arial','Helvetica','sans-serif';">the estimation of the expected usage and the estimated relative standalone selling price of the incentive points and coupons, and valuation of financial instruments measured at fair value. Actual results could differ from those estimates</span><span style="font-family:'Arial','Helvetica','sans-serif';">.</span></p>
CY2023Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
7.8109
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
3200000
CY2022 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
15619000
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
18080000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0468
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0458
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
108949000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
76249000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
146560000
CY2021 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2022 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2023 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 18pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Significant Risks and Uncertainties</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><span style="font-family:'Arial','Helvetica','sans-serif';">1)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><span style="font-family:'Arial','Helvetica','sans-serif';">Currency risk</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Currency risk arises from the possibility that fluctuations in foreign exchange rates will impact the financial instruments. The Group is not exposed to significant transactional foreign currency risk since almost all of its transactions, assets and liability are denominated in Hong Kong dollars and U.S. dollars and Hong Kong dollars are pegged against U.S. dollars. The impact of foreign currency fluctuations in the Group’s earnings is included in “Others, net” in the consolidated statements of comprehensive income. At the same time, the Group is exposed to translational foreign currency risk since some of the Company’s major subsidiaries have RMB as their functional currency. Therefore, RMB depreciation against Hong Kong dollars could have a material adverse impact on the foreign currency translation adjustment in the consolidated statements of comprehensive income. The Group enters into currency futures contracts to manage currency exposure associated with anticipated receipts and disbursements occurring in a currency other than the functional currency of the entity. The overall impact of the currency risk of other foreign currency assets held by the Group other than U.S. dollars and RMB is not significant.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">As of December 31, 2022 and 2023, the Group had RMB-denominated net assets of HK</span><span style="font-family:'Arial','Helvetica','sans-serif';">$1,727.2</span><span style="font-family:'Arial','Helvetica','sans-serif';"> million and net liabilities of HK$</span><span style="font-family:'Arial','Helvetica','sans-serif';">3,711.1</span><span style="font-family:'Arial','Helvetica','sans-serif';"> million, respectively. We estimate that a </span><span style="font-family:'Arial','Helvetica','sans-serif';">10%</span><span style="font-family:'Arial','Helvetica','sans-serif';"> depreciation of RMB against the U.S. dollar based on the foreign exchange rate on December 31, 2022 and 2023, would result in a decrease of US$</span><span style="font-family:'Arial','Helvetica','sans-serif';">22.2</span><span style="font-family:'Arial','Helvetica','sans-serif';"> million and an increase of US$</span><span style="font-family:'Arial','Helvetica','sans-serif';">47.5</span><span style="font-family:'Arial','Helvetica','sans-serif';"> million, respectively, in the Group’s pre-tax profit for the years ended December 31, 2022 and 2023. We estimate that a </span><span style="font-family:'Arial','Helvetica','sans-serif';">10%</span><span style="font-family:'Arial','Helvetica','sans-serif';"> appreciation of RMB against the U.S. dollar based on the foreign exchange rate on December 31, 2022 and 2023 would result in an increase of US</span><span style="font-family:'Arial','Helvetica','sans-serif';">$22.2</span><span style="font-family:'Arial','Helvetica','sans-serif';"> million and a decrease of US$</span><span style="font-family:'Arial','Helvetica','sans-serif';">47.5</span><span style="font-family:'Arial','Helvetica','sans-serif';"> million, respectively, in the Group’s pre-tax profit for the years ended December 31, 2022 and 2023.</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><span style="font-family:'Arial','Helvetica','sans-serif';">2)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><span style="font-family:'Arial','Helvetica','sans-serif';">Credit risk</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Cash held on behalf of clients are segregated and deposited in financial institutions as required by rules mandated by the Group’s primary regulators. These financial institutions are of sound credit ratings, therefore the Group believes that there is no significant credit risk related to cash held on behalf of clients.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">The Group’s securities and derivative trades activities are transacted on either a cash or margin basis. The Group’s credit risk is limited in that substantially all of the contracts entered into are settled directly at securities and derivatives clearing organizations. In margin transactions, the Group extends credit to the client, subject to various regulatory and internal margin requirements, collateralized by cash and securities in the client’s account. IPO loans are exposed to credit risk from clients who fails to repay the loans upon IPO stock allotment. The Group monitors the clients’ collateral level and has the right to dispose the newly allotted stocks once the stocks first start trading. Stock-pledged loans to enterprise pledged by listed shares are exposed to credit risk from counterparties who fail to repay the loans, the Group monitors on the collateral level of stock-pledged loans in real time, and has the right to dispose of the pledged listed shares once the collateral level falls under the minimal level required to get the loans repaid. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Liabilities to other brokers and dealers related to unsettled transactions are recorded at the amount for which the securities were purchased, and are paid upon receipt of the securities from other brokers or dealers.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 18pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Significant Risks and Uncertainties (Continued)</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';font-style:normal;">2)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';font-style:normal;">Credit risk (Continued)</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">In connection with its clearing activities, the Group is obligated to settle transactions with brokers and other financial institutions even if its clients fail to meet their obligations to the Group. Clients are required to complete their transactions by the settlement date, generally two business days after the trade date. If clients do not fulfill their contractual obligations, the Group may incur losses. The Group has established procedures to reduce this risk by generally requiring that clients deposit sufficient cash and/or securities into their account prior to placing an order.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">For cash management purposes, the Group enters into short-term securities purchased under agreements to resale transactions (“reverse repos”) in addition to securities borrowing and lending arrangements, all of which may result in credit exposure in the event the counterparty to a transaction is unable to fulfill its contractual obligations. Reverse repos are collateralized by securities with a market value in excess of the obligation under the contract. Similarly, securities lending agreements are collateralized by deposits of cash or securities. The Group attempts to minimize credit risk associated with these activities by monitoring collateral values on a daily basis and requiring additional collateral to be deposited with or returned to the Group as permitted under contractual provisions.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-align:justify;margin:0pt 0pt 12pt 18pt;"><i style="font-family:'Arial','Helvetica','sans-serif';">Concentrations of Credit Risk</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">The Group’s exposure to credit risk associated with its brokerage and other activities is measured on an individual counterparty basis, as well as by groups of counterparties that share similar attributes. There was no revenue from clients which individually represented greater than 10% of the total revenues for the years ended December 31, 2021, 2022 and 2023, respectively. Concentrations of credit risk can be affected by changes in political, industry, or economic factors. To reduce the potential for risk concentration, credit limits are established and exposure is monitored in light of changing counterparty and market conditions. As of December 31, 2022 and 2023, the Group did not have any material concentrations of credit risk within or outside the ordinary course of business.</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><span style="font-family:'Arial','Helvetica','sans-serif';">3)</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><span style="font-family:'Arial','Helvetica','sans-serif';">Interest rate risk</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Fluctuations in market interest rates may negatively affect the Group’s financial condition and results of operations. The Group are exposed to floating interest rate risk on cash deposit and floating rate borrowings. We use net interest simulation modeling techniques to evaluate the effect that changes in interest rates might have on pre-tax profit or loss. The model includes all interest-sensitive assets and liabilities. The simulations involve assumptions that are inherently uncertain and, as a result, cannot precisely predict the impact that changes in interest rates will have on pre-tax profit or loss. Actual results may differ from simulated results due to differences in timing and frequency of rate changes, changes in market conditions and changes in management strategy that lead to changes in the mix of interest-sensitive assets and liabilities.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">The simulations assume that the asset and liability structure of the consolidated balance sheets would not be changed as a result of a simulated change in interest rates. The results of the simulations based on the Group’s financial position as of December 31, 2023 indicate that a </span><span style="font-family:'Arial','Helvetica','sans-serif';">1%</span><span style="font-family:'Arial','Helvetica','sans-serif';"> (100 basis points) increase/ decrease in interest rates over a 12-month period would have increased/decreased the Group’s profit before tax by approximately HK</span><span style="font-family:'Arial','Helvetica','sans-serif';">$302.9</span><span style="font-family:'Arial','Helvetica','sans-serif';"> million (US</span><span style="font-family:'Arial','Helvetica','sans-serif';">$38.8</span><span style="font-family:'Arial','Helvetica','sans-serif';"> million), depending largely on the extent and timing of possible changes in floating rates.</span></p>
CY2023Q4 us-gaap Derivative Basis Spread On Variable Rate
DerivativeBasisSpreadOnVariableRate
0.01
CY2023 us-gaap Gain On Derivative Instruments Pretax
GainOnDerivativeInstrumentsPretax
302900000
CY2023 us-gaap Gain On Derivative Instruments Pretax
GainOnDerivativeInstrumentsPretax
38800000
CY2023 futu New Accounting Standards Which Have Not Yet Been Adopted
NewAccountingStandardsWhichHaveNotYetBeenAdopted
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';font-style:italic;font-weight:bold;">New accounting standards which have not yet been adopted</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update requires disclosure of incremental segment information on an annual and interim basis. This update is effective for annual periods beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024. Early adoption is permitted. This guidance should be applied retrospectively to all prior periods presented in the financial statements. The Group is currently evaluating the impact on its financial statements of adopting this guidance.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires that public entities on an annual basis, (1) in the rate reconciliation, disclose specific categories and provide additional information for reconciling items that meet a quantitative threshold; (2) about income taxes paid, disclose the amount of income taxes paid (net of refunds received) disaggregated by federal, state, and foreign taxes and by individual jurisdiction in which income taxes paid (net of refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received); and (3) disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign and income tax expense (or benefit) disaggregated by federal, state, and foreign. This update is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. This guidance should be applied on a prospective basis. Retrospective application is permitted. The Group is currently evaluating the impact on its financial statements of adopting this guidance.</span></p>
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
8181000
CY2022Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
1911000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
10092000
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
149348000
CY2023Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
31394000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
180742000
CY2023Q4 futu Unfunded Commitment Fair Value Disclosure
UnfundedCommitmentFairValueDisclosure
0
CY2022Q4 futu Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2023Q4 futu Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
675064000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
3114613000
CY2021 us-gaap Interest Income Short Term Investment Other
InterestIncomeShortTermInvestmentOther
0
CY2022 us-gaap Interest Income Short Term Investment Other
InterestIncomeShortTermInvestmentOther
23059000
CY2023 us-gaap Interest Income Short Term Investment Other
InterestIncomeShortTermInvestmentOther
68323000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
196864000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
224092000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
211143000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
238017000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
106459000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
119854000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
122333000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
116684000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
104637000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
24745000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2048000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
248114000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10097000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
238017000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
26740963000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
32593304000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
27840000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
45949000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
26713123000
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
32547355000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
27840000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
45949000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
279791000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
301138000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
133954000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
176174000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
145837000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
124964000
CY2021 us-gaap Depreciation
Depreciation
34118000
CY2021 us-gaap Depreciation
Depreciation
34118000
CY2022 us-gaap Depreciation
Depreciation
48014000
CY2022 us-gaap Depreciation
Depreciation
48014000
CY2023 us-gaap Depreciation
Depreciation
43702000
CY2023 us-gaap Depreciation
Depreciation
43702000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
66847000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
101483000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12399000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
29412000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
54448000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
72071000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2317000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6700000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17147000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
224042000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
222870000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
15652000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
15686000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
239694000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
238556000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
224042000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
222870000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
7798000
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
11767000
CY2022Q4 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
0
CY2023Q4 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
0
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
235434000
CY2022Q4 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
0
CY2023Q4 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
0
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
15652000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
15686000
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
15596000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
0
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
0
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
52863000
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
57932000
CY2022Q4 futu Staff Advances
StaffAdvances
18685000
CY2023Q4 futu Staff Advances
StaffAdvances
17667000
CY2022Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
30710000
CY2023Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
59880000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
102258000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
135479000
CY2022Q4 futu Refundable Deposit
RefundableDeposit
680356000
CY2023Q4 futu Refundable Deposit
RefundableDeposit
932899000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
145837000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
124964000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
84564000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
96820000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
54448000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
72071000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
965205000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1226754000
CY2022Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0386
CY2023Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0530
CY2022Q4 futu Line Of Credit Facility Committed Remaining Borrowing Capacity
LineOfCreditFacilityCommittedRemainingBorrowingCapacity
0
CY2023Q4 futu Line Of Credit Facility Committed Remaining Borrowing Capacity
LineOfCreditFacilityCommittedRemainingBorrowingCapacity
586178000
CY2022Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
868646000
CY2023Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
1175838000
CY2022Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
267619000
CY2023Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
327623000
CY2022Q4 futu Payables To Corporate Clients In Relation To Esop Management Services
PayablesToCorporateClientsInRelationToEsopManagementServices
314385000
CY2023Q4 futu Payables To Corporate Clients In Relation To Esop Management Services
PayablesToCorporateClientsInRelationToEsopManagementServices
166879000
CY2022Q4 us-gaap Accrued Advertising Current And Noncurrent
AccruedAdvertisingCurrentAndNoncurrent
72137000
CY2023Q4 us-gaap Accrued Advertising Current And Noncurrent
AccruedAdvertisingCurrentAndNoncurrent
80655000
CY2022Q4 futu Temporary Payables In Relation To Fund Distribution Services
TemporaryPayablesInRelationToFundDistributionServices
18725000
CY2023Q4 futu Temporary Payables In Relation To Fund Distribution Services
TemporaryPayablesInRelationToFundDistributionServices
45523000
CY2022Q4 futu Stamp Duty Trading Levy And Trading Fee Payables
StampDutyTradingLevyAndTradingFeePayables
26597000
CY2023Q4 futu Stamp Duty Trading Levy And Trading Fee Payables
StampDutyTradingLevyAndTradingFeePayables
31209000
CY2022Q4 futu Accrued Processing And Servicing Cost Current
AccruedProcessingAndServicingCostCurrent
30462000
CY2023Q4 futu Accrued Processing And Servicing Cost Current
AccruedProcessingAndServicingCostCurrent
34977000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
31083000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
15958000
CY2022Q4 futu Payables In Relation To Acquisition Current
PayablesInRelationToAcquisitionCurrent
19196000
CY2023Q4 futu Payables In Relation To Acquisition Current
PayablesInRelationToAcquisitionCurrent
1660000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
57309000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
58682000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1706159000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1939004000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7414000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
6326000
CY2022Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
6206000
CY2023Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
5857000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13620000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12183000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
807500
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0050
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
403750000
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2016Q3 futu Number Of Votes Per Share
NumberOfVotesPerShare
1
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
5.13
CY2022 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
4.56
CY2023 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
4.60
CY2023 futu Required Portion Of After Tax Profit Appropriated To General Reserve Fund Under Prc Law
RequiredPortionOfAfterTaxProfitAppropriatedToGeneralReserveFundUnderPrcLaw
0.10
CY2023 futu Required General Reserve Fund Registered Capital Ratio To De Force Compulsory Net Profit Allocation To General Reserve Fund
RequiredGeneralReserveFundRegisteredCapitalRatioToDeForceCompulsoryNetProfitAllocationToGeneralReserveFund
0.50
CY2022Q4 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
304377000
CY2023Q4 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
304377000
CY2023Q4 us-gaap Restricted Investments Percent Of Net Assets
RestrictedInvestmentsPercentOfNetAssets
0.25
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
98913000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
204529000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
290831000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7259362
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.5533
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y7M17D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
45556000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4515026
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.5643
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y10M13D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
28284000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2744336
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.5351
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y10M20D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
17272000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0413
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.40
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.40
CY2021 futu Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0.15
CY2023 futu Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0.15
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2810210000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2926944000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4281474000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1200912670
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1139377763
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1104899411
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.34
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.57
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.88
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2810210000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2926944000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4281474000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1200912670
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1139377763
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1104899411
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1219672508
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1151021697
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1119653571
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.30
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.54
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.82
CY2022Q4 us-gaap Fair Value Of Securities Received As Collateral That Can Be Resold Or Repledged
FairValueOfSecuritiesReceivedAsCollateralThatCanBeResoldOrRepledged
109296132000
CY2023Q4 us-gaap Fair Value Of Securities Received As Collateral That Can Be Resold Or Repledged
FairValueOfSecuritiesReceivedAsCollateralThatCanBeResoldOrRepledged
127758188000
CY2022Q4 us-gaap Due From Correspondent Brokers
DueFromCorrespondentBrokers
48349000
CY2023Q4 us-gaap Due From Correspondent Brokers
DueFromCorrespondentBrokers
203500000
CY2022Q4 us-gaap Fair Value Of Securities Received As Collateral That Have Been Resold Or Repledged
FairValueOfSecuritiesReceivedAsCollateralThatHaveBeenResoldOrRepledged
12326953000
CY2023Q4 us-gaap Fair Value Of Securities Received As Collateral That Have Been Resold Or Repledged
FairValueOfSecuritiesReceivedAsCollateralThatHaveBeenResoldOrRepledged
13326597000
CY2022Q4 futu Securities Borrowed And Loaned Net
SecuritiesBorrowedAndLoanedNet
12786899000
CY2023Q4 futu Securities Borrowed And Loaned Net
SecuritiesBorrowedAndLoanedNet
16106157000
CY2022Q4 us-gaap Securities Received As Collateral
SecuritiesReceivedAsCollateral
14874210000
CY2023Q4 us-gaap Securities Received As Collateral
SecuritiesReceivedAsCollateral
18707651000
CY2022Q4 us-gaap Cash Collateral For Borrowed Securities
CashCollateralForBorrowedSecurities
1889795000
CY2023Q4 us-gaap Cash Collateral For Borrowed Securities
CashCollateralForBorrowedSecurities
2663837000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3913027000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4007642000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3944779000
CY2021 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
197390000
CY2022 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
986387000
CY2023 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
2482866000
CY2021 futu Interest Income Margin Financing
InterestIncomeMarginFinancing
1720473000
CY2022 futu Interest Income Margin Financing
InterestIncomeMarginFinancing
1588569000
CY2023 futu Interest Income Margin Financing
InterestIncomeMarginFinancing
1754056000
CY2021 futu Interest Income Securities Lending
InterestIncomeSecuritiesLending
397505000
CY2022 futu Interest Income Securities Lending
InterestIncomeSecuritiesLending
499745000
CY2023 futu Interest Income Securities Lending
InterestIncomeSecuritiesLending
1053294000
CY2021 futu Interest Income Stock Pledged Loan
InterestIncomeStockPledgedLoan
1872000
CY2022 futu Interest Income Stock Pledged Loan
InterestIncomeStockPledgedLoan
135733000
CY2023 futu Interest Income Stock Pledged Loan
InterestIncomeStockPledgedLoan
170566000
CY2023 us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
68556000
CY2021 futu Interest Income Initial Public Offering And Other Financing
InterestIncomeInitialPublicOfferingAndOtherFinancing
200958000
CY2022 futu Interest Income Initial Public Offering And Other Financing
InterestIncomeInitialPublicOfferingAndOtherFinancing
3893000
CY2023 futu Interest Income Initial Public Offering And Other Financing
InterestIncomeInitialPublicOfferingAndOtherFinancing
7084000
CY2021 us-gaap Interest Income Operating
InterestIncomeOperating
2518198000
CY2022 us-gaap Interest Income Operating
InterestIncomeOperating
3214327000
CY2023 us-gaap Interest Income Operating
InterestIncomeOperating
5536422000
CY2021 futu Funds Distribution Service Income
FundsDistributionServiceIncome
68856000
CY2022 futu Funds Distribution Service Income
FundsDistributionServiceIncome
96676000
CY2023 futu Funds Distribution Service Income
FundsDistributionServiceIncome
265686000
CY2021 futu Currency Exchange Service Income
CurrencyExchangeServiceIncome
201030000
CY2022 futu Currency Exchange Service Income
CurrencyExchangeServiceIncome
141322000
CY2023 futu Currency Exchange Service Income
CurrencyExchangeServiceIncome
133644000
CY2021 us-gaap Market Data Revenue
MarketDataRevenue
43921000
CY2022 us-gaap Market Data Revenue
MarketDataRevenue
41498000
CY2023 us-gaap Market Data Revenue
MarketDataRevenue
37053000
CY2021 futu Public Relations Service Charge Income
PublicRelationsServiceChargeIncome
96327000
CY2022 futu Public Relations Service Charge Income
PublicRelationsServiceChargeIncome
44033000
CY2023 futu Public Relations Service Charge Income
PublicRelationsServiceChargeIncome
25941000
CY2021 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
86880000
CY2022 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
25350000
CY2023 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
16090000
CY2021 futu Initial Public Offer Subscription Service Charge Income
InitialPublicOfferSubscriptionServiceChargeIncome
169336000
CY2022 futu Initial Public Offer Subscription Service Charge Income
InitialPublicOfferSubscriptionServiceChargeIncome
6513000
CY2023 futu Initial Public Offer Subscription Service Charge Income
InitialPublicOfferSubscriptionServiceChargeIncome
3714000
CY2021 futu Miscellaneous Income
MiscellaneousIncome
17745000
CY2022 futu Miscellaneous Income
MiscellaneousIncome
36666000
CY2023 futu Miscellaneous Income
MiscellaneousIncome
45089000
CY2021 us-gaap Other Income
OtherIncome
684095000
CY2022 us-gaap Other Income
OtherIncome
392058000
CY2023 us-gaap Other Income
OtherIncome
527217000
CY2023 us-gaap Interest Expense
InterestExpense
910759000
CY2021 futu Brokerage Commission And Handling Charge Expenses
BrokerageCommissionAndHandlingChargeExpenses
572159000
CY2022 futu Brokerage Commission And Handling Charge Expenses
BrokerageCommissionAndHandlingChargeExpenses
329789000
CY2023 futu Brokerage Commission And Handling Charge Expenses
BrokerageCommissionAndHandlingChargeExpenses
249567000
CY2021 futu Interest Expenses For Securities Borrowed Borrowings From Brokers
InterestExpensesForSecuritiesBorrowedBorrowingsFromBrokers
18624000
CY2022 futu Interest Expenses For Securities Borrowed Borrowings From Brokers
InterestExpensesForSecuritiesBorrowedBorrowingsFromBrokers
183138000
CY2023 futu Interest Expenses For Securities Borrowed Borrowings From Brokers
InterestExpensesForSecuritiesBorrowedBorrowingsFromBrokers
722310000
CY2021 futu Interest Expenses For Securities Borrowed Borrowings From Clients
InterestExpensesForSecuritiesBorrowedBorrowingsFromClients
132034000
CY2022 futu Interest Expenses For Securities Borrowed Borrowings From Clients
InterestExpensesForSecuritiesBorrowedBorrowingsFromClients
26650000
CY2023 futu Interest Expenses For Securities Borrowed Borrowings From Clients
InterestExpensesForSecuritiesBorrowedBorrowingsFromClients
15467000
CY2021 futu Interest Expense Borrowings Banks
InterestExpenseBorrowingsBanks
125002000
CY2022 futu Interest Expense Borrowings Banks
InterestExpenseBorrowingsBanks
74397000
CY2023 futu Interest Expense Borrowings Banks
InterestExpenseBorrowingsBanks
171451000
CY2021 futu Interest Expense Other Licensed Financial Institutions
InterestExpenseOtherLicensedFinancialInstitutions
51179000
CY2022 futu Interest Expense Other Licensed Financial Institutions
InterestExpenseOtherLicensedFinancialInstitutions
8318000
CY2023 futu Interest Expense Other Licensed Financial Institutions
InterestExpenseOtherLicensedFinancialInstitutions
131000
CY2021 futu Interest Expenses For Other Businesses
InterestExpensesForOtherBusinesses
50063000
CY2023 futu Interest Expenses For Other Businesses
InterestExpensesForOtherBusinesses
1400000
CY2021 us-gaap Interest Expense
InterestExpense
376902000
CY2022 us-gaap Interest Expense
InterestExpense
292503000
CY2021 futu Cloud Service Fee
CloudServiceFee
122269000
CY2022 futu Cloud Service Fee
CloudServiceFee
216140000
CY2023 futu Cloud Service Fee
CloudServiceFee
181241000
CY2021 futu Market Information And Data Fee
MarketInformationAndDataFee
70387000
CY2022 futu Market Information And Data Fee
MarketInformationAndDataFee
79439000
CY2023 futu Market Information And Data Fee
MarketInformationAndDataFee
82026000
CY2021 futu System Cost
SystemCost
12160000
CY2022 futu System Cost
SystemCost
28324000
CY2023 futu System Cost
SystemCost
58709000
CY2021 futu Data Transmission Fee
DataTransmissionFee
46289000
CY2022 futu Data Transmission Fee
DataTransmissionFee
41775000
CY2023 futu Data Transmission Fee
DataTransmissionFee
44718000
CY2021 futu Other Processing And Servicing Costs
OtherProcessingAndServicingCosts
5898000
CY2022 futu Other Processing And Servicing Costs
OtherProcessingAndServicingCosts
8162000
CY2023 futu Other Processing And Servicing Costs
OtherProcessingAndServicingCosts
9210000
CY2021 futu Processing And Servicing Costs
ProcessingAndServicingCosts
257003000
CY2022 futu Processing And Servicing Costs
ProcessingAndServicingCosts
373840000
CY2023 futu Processing And Servicing Costs
ProcessingAndServicingCosts
375904000
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1248682000
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2067204000
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2539858000
CY2021 us-gaap Marketing Expense
MarketingExpense
1163495000
CY2022 us-gaap Marketing Expense
MarketingExpense
548348000
CY2023 us-gaap Marketing Expense
MarketingExpense
461594000
CY2021 futu Processing And Servicing Costs
ProcessingAndServicingCosts
257003000
CY2022 futu Processing And Servicing Costs
ProcessingAndServicingCosts
373840000
CY2023 futu Processing And Servicing Costs
ProcessingAndServicingCosts
375904000
CY2021 futu Brokerage Commission And Handling Charge Expenses
BrokerageCommissionAndHandlingChargeExpenses
572159000
CY2022 futu Brokerage Commission And Handling Charge Expenses
BrokerageCommissionAndHandlingChargeExpenses
329789000
CY2023 futu Brokerage Commission And Handling Charge Expenses
BrokerageCommissionAndHandlingChargeExpenses
249567000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
106459000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
119854000
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
157898000
CY2021 us-gaap Professional Fees
ProfessionalFees
59697000
CY2022 us-gaap Professional Fees
ProfessionalFees
135167000
CY2023 us-gaap Professional Fees
ProfessionalFees
69324000
CY2021 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
36435000
CY2022 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
54714000
CY2023 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
60849000
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
111675000
CY2022 us-gaap Other Noninterest Expense
OtherNoninterestExpense
123706000
CY2023 us-gaap Other Noninterest Expense
OtherNoninterestExpense
175182000
CY2021 us-gaap Noninterest Expense
NoninterestExpense
3555605000
CY2022 us-gaap Noninterest Expense
NoninterestExpense
3752622000
CY2023 us-gaap Noninterest Expense
NoninterestExpense
4090176000
CY2023 futu Withholding Tax Rate
WithholdingTaxRate
0.10
CY2023 futu Reduced Withholding Tax Rate
ReducedWithholdingTaxRate
0.05
CY2023 futu Withholding Tax Rate
WithholdingTaxRate
0.10
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
396512000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
466074000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
763248000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-21431000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-52112000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-14769000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
375081000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
413962000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
748479000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3185291000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3358607000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5040925000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
524907000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
554005000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
831588000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
101653000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-46798000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
65581000
CY2021 futu Income Tax Rate Reconciliation Tax Effect Of Permanent Differences
IncomeTaxRateReconciliationTaxEffectOfPermanentDifferences
22047000
CY2022 futu Income Tax Rate Reconciliation Tax Effect Of Permanent Differences
IncomeTaxRateReconciliationTaxEffectOfPermanentDifferences
41181000
CY2023 futu Income Tax Rate Reconciliation Tax Effect Of Permanent Differences
IncomeTaxRateReconciliationTaxEffectOfPermanentDifferences
49787000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-32182000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
50807000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
20873000
CY2021 futu Income Tax Reconciliation Super Deduction Of Research And Development Expenses
IncomeTaxReconciliationSuperDeductionOfResearchAndDevelopmentExpenses
-62966000
CY2022 futu Income Tax Reconciliation Super Deduction Of Research And Development Expenses
IncomeTaxReconciliationSuperDeductionOfResearchAndDevelopmentExpenses
-86419000
CY2023 futu Income Tax Reconciliation Super Deduction Of Research And Development Expenses
IncomeTaxReconciliationSuperDeductionOfResearchAndDevelopmentExpenses
-132704000
CY2021 us-gaap Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
-602000
CY2022 us-gaap Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
-3614000
CY2023 us-gaap Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
11756000
CY2021 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
177776000
CY2022 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
95200000
CY2023 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
98402000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
375081000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
413962000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
748479000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
129248000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
187154000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
79098000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
98227000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
122624000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
188205000
CY2022Q4 futu Deferred Tax Assets Including Set Off Of Deferred Tax Liabilities
DeferredTaxAssetsIncludingSetOffOfDeferredTaxLiabilities
85722000
CY2023Q4 futu Deferred Tax Assets Including Set Off Of Deferred Tax Liabilities
DeferredTaxAssetsIncludingSetOffOfDeferredTaxLiabilities
97176000
CY2022Q4 futu Deferred Tax Assets Set Off Of Deferred Tax Liabilities
DeferredTaxAssetsSetOffOfDeferredTaxLiabilities
1158000
CY2023Q4 futu Deferred Tax Assets Set Off Of Deferred Tax Liabilities
DeferredTaxAssetsSetOffOfDeferredTaxLiabilities
356000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
84564000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
96820000
CY2022Q4 futu Deferred Tax Liabilities Including Set Off Of Deferred Tax Assets
DeferredTaxLiabilitiesIncludingSetOffOfDeferredTaxAssets
8572000
CY2023Q4 futu Deferred Tax Liabilities Including Set Off Of Deferred Tax Assets
DeferredTaxLiabilitiesIncludingSetOffOfDeferredTaxAssets
6682000
CY2022Q4 futu Deferred Tax Liability Set Off Of Deferred Tax Assets
DeferredTaxLiabilitySetOffOfDeferredTaxAssets
1158000
CY2023Q4 futu Deferred Tax Liability Set Off Of Deferred Tax Assets
DeferredTaxLiabilitySetOffOfDeferredTaxAssets
356000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7414000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
6326000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
67769000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
169422000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
122624000
CY2021 futu Valuation Allowance Deferred Tax Asset Additions Amount
ValuationAllowanceDeferredTaxAssetAdditionsAmount
108347000
CY2022 futu Valuation Allowance Deferred Tax Asset Additions Amount
ValuationAllowanceDeferredTaxAssetAdditionsAmount
97727000
CY2023 futu Valuation Allowance Deferred Tax Asset Additions Amount
ValuationAllowanceDeferredTaxAssetAdditionsAmount
77016000
CY2021 futu Valuation Allowance Deferred Tax Asset Reversals Amount
ValuationAllowanceDeferredTaxAssetReversalsAmount
6694000
CY2022 futu Valuation Allowance Deferred Tax Asset Reversals Amount
ValuationAllowanceDeferredTaxAssetReversalsAmount
144525000
CY2023 futu Valuation Allowance Deferred Tax Asset Reversals Amount
ValuationAllowanceDeferredTaxAssetReversalsAmount
11435000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
169422000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
122624000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
188205000
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
671237000
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
877231000
CY2022Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
625688000
CY2023Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
877231000
CY2022 us-gaap Investment Company Committed Capital
InvestmentCompanyCommittedCapital
74000000
CY2023 us-gaap Investment Company Committed Capital
InvestmentCompanyCommittedCapital
72500000
CY2021 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
165885000
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
175717000
CY2023 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
159435000

Files In Submission

Name View Source Status
0001104659-24-051213-index-headers.html Edgar Link pending
0001104659-24-051213-index.html Edgar Link pending
0001104659-24-051213.txt Edgar Link pending
0001104659-24-051213-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
futu-20231231.xsd Edgar Link pending
futu-20231231x20f.htm Edgar Link pending
futu-20231231x20f001.jpg Edgar Link pending
futu-20231231x20f005.jpg Edgar Link pending
futu-20231231x20f013.jpg Edgar Link pending
futu-20231231xex12d1.htm Edgar Link pending
futu-20231231xex12d2.htm Edgar Link pending
futu-20231231xex13d1.htm Edgar Link pending
futu-20231231xex13d2.htm Edgar Link pending
futu-20231231xex15d1.htm Edgar Link pending
futu-20231231xex15d2.htm Edgar Link pending
futu-20231231xex15d3.htm Edgar Link pending
futu-20231231xex8d1.htm Edgar Link pending
futu-20231231xex97d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
R124.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
futu-20231231_def.xml Edgar Link unprocessable
futu-20231231_lab.xml Edgar Link unprocessable
futu-20231231_pre.xml Edgar Link unprocessable
futu-20231231x20f_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
futu-20231231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable